INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 September 2015
|
Net Assets |
£209m |
|
Net Assets per share |
522p |
|
Share price |
455p |
|
Total value of unquoted investments |
£21m |
|
Total number of portfolio companies |
99 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
9.6 |
|
Gilead |
8.0 |
|
Regeneron |
7.0 |
|
Biogen |
6.8 |
|
Incyte |
4.8 |
|
Alexion |
4.8 |
|
Amgen |
4.6 |
|
Opthotech |
4.3 |
|
Vertex |
3.7 |
|
Biomarin |
2.8 |
|
|
----------- |
|
Total |
56.4 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
53 |
|
Turning Profitable 2015 |
11 |
|
Unprofitable |
36 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
84 |
|
Europe & UK |
16 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
91 |
|
Unquoted |
9 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
2 NOVEMBER 2015